The North America Cannabis Market was valued at $67988.6 Million in 2025 and projected to reach to $110493.6 Million by 2030, representing a compound annual growth rate of 10.2%. North America's cannabis market is positioned for sustained expansion through 2030, supported by ongoing regulatory liberalization and shifting consumer perceptions.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
North America's cannabis market is valued at $67,988.6 million in 2025, with a projected CAGR of 10.2% through 2030, reaching $110,493.6 million. This represents the world's largest regional cannabis market, significantly outpacing global growth rates.
The United States commands 87.4% of North America's cannabis market at $94,032.3 million, driven by widespread state-level legalization, mature retail infrastructure, and established consumer demand across medical and recreational segments.
Progressive legalization frameworks across North American jurisdictions continue to unlock new market opportunities. Multiple US states, Canadian provinces, and Mexican regions are implementing cannabis regulations, expanding addressable markets and consumer accessibility.
Increasing consumer acceptance in North America is driving product diversification beyond traditional flower into edibles, beverages, concentrates, and wellness products. This expansion attracts mainstream retailers and CPG companies into the cannabis ecosystem.
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | CBD HEMP OIL (Type) |
| Forecast Period | 2025–2030 |
| Growth Rate | CAGR of 11.5% from 2025 to 2030 |
| Largest Segment | MARIJUANA (Source) |
| Market Size Base Year (Billions) | ~USD 72.97 (2025) |
| Revenue Forecast (Billions) | ~USD 125.76 (2030) |
| Segments Covered | Compound Type, Product Type, Application, Source, Type, Product & Software |
6 segment dimensions are covered across the global market.
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| CANNABIS SCIENCE INC. | United States | Private Company | Oil/Tinctures & Extracts (incl. water-soluble CBDA/CBD),Nutraceutical & Wellness Products,Cosmeceuticals / Topicals, |
| CANOPY GROWTH CORPORATION | Canada | Public Company | Flowers/Buds & Pre-rolls (THC-dominant and Balanced),Oil/Tinctures & Extracts (Medical and Adult-use),Edibles & Beverages, |
| CURALEAF, INC. | United States | Public Company | Flowers/Buds,Oil/Tinctures,Edibles, |
| GREEN THUMB INDUSTRIES | United States | Public Company | Flowers/Buds,Oil/Tinctures & Concentrates/Vapes,Edibles, |
| TILRAY BRANDS, INC. | Canada | Public Company | THC-dominant Flowers/Buds,THC-dominant Oils/Tinctures & Extracts,Edibles & Beverages (THC/CBD), |
| TRULIEVE | United States | Public Company | Flowers/Buds,Oil/Tinctures,Edibles, |
| CRESCO LABS | United States | Public Company | Flowers/Buds,Oil/Tinctures,Edibles, |
| AURORA CANNABIS INC. | Canada | Public Company | Flowers/Buds,Oil/Tinctures,Edibles, |
| ORGANIGRAM GLOBAL | Canada | Public Company | Flowers/Buds (including pre-rolls and infused pre-rolls),Oil/Tinctures, Vapes, Concentrates,Edibles & Beverages (including gummies), |
| TERRASCEND | Canada | Public Company | Flowers/Buds,Oil/Tinctures,Edibles, |
| BLüM HOLDINGS INC. | United States | Public Company | Flowers/Buds (THC-dominant, marijuana source),Edibles & Concentrates (Korova, THC-dominant),Oil/Tinctures (medical and wellness-leaning), |
| VILLAGE FARMS INTERNATIONAL INC. | United States | Public Company | Flowers/Buds,Oil/Tinctures,Edibles, |
| THE CRONOS GROUP | Canada | Public Company | Flowers/Buds,Oil/Tinctures,Edibles, |
| MEDICAL MARIJUANA, INC. | United States | Public Company | CBD-dominant Oil/Tinctures,CBD-dominant Edibles & Ingestibles,Topicals (CBD-focused), |
| MEDIPHARM LABS | Canada | Public Company | Oil/Tinctures & Concentrates (THC-dominant, CBD-dominant, Balanced),Dried Flower & Pre-rolls,Nutraceutical & Wellness Derivatives, |
Cannabis Science Inc. is a private cannabis company founded in 1996 and based in the United States.
Canopy Growth Corporation is a Canadian public company with 1,128 employees operating in the cannabis industry.
Curaleaf, Inc. is a publicly traded cannabis company based in the United States with 5,554 employees.
Green Thumb Industries is a U.S.-based public cannabis company founded in 2014 with 4,900 employees.
Tilray Brands, Inc. is a Canadian public cannabis company with 3,595 employees.
Trulieve is a publicly traded cannabis retailer founded in 1940 in the United States with 5,000 employees.
Cresco Labs is a U.S.-based public cannabis company with 2,900 employees.
Aurora Cannabis Inc. is a Canadian public cannabis company founded in 2013 with 1,028 employees.
Organigram Global is a Canadian public cannabis company with 1,120 employees.
TerrAscend is a Canadian public cannabis company founded in 2017 with 933 employees.
Blüm Holdings Inc. is a U.S.-based public cannabis company founded in 2010 with 133 employees.
Village Farms International Inc. is a U.S.-based public company founded in 1989 with 1,128 employees.
The Cronos Group is a Canadian public cannabis company with 610 employees.
Medical Marijuana, Inc. is a U.S.-based public cannabis company founded in 2005 with 91 employees.
Medipharm Labs is a Canadian public cannabis company founded in 2015 with 127 employees.
| Country | 2025 size (native) |
|---|---|
| US | USD 94032.3 Million |
| Canada | USD 12119.4 Million |
| Mexico | USD 4341.9 Million |
North America's cannabis market is projected to reach $110,493.6 million by 2030, growing from $67,988.6 million in 2025 at a 10.2% CAGR.
North America's cannabis market growth is driven by progressive legalization, increasing consumer acceptance, expanding retail infrastructure, product innovation in food and beverages, and growing medical applications across multiple jurisdictions.
North America's 10.2% CAGR slightly trails the global average of 11.5%, but North America maintains the largest absolute market size and most mature regulatory environment, positioning it as the dominant regional market.
North America's fastest-growing segments include cannabis-infused beverages, premium edibles, wellness-focused products, and functional food items targeting health-conscious consumers seeking alternatives to traditional pharmaceuticals and alcohol.
North America's market leadership is concentrated in Canada, California, Colorado, and other states with established legal frameworks, though emerging markets in additional U.S. states and Canadian provinces continue expanding regulatory access.
The study employed two main methods to estimate the current size of the cannabis market. Comprehensive secondary research was conducted to gather information on the market, peer markets, and parent markets. The next stage involved validating these findings, assumptions, and estimates with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were used to determine the overall market size. Subsequently, market segmentation and data triangulation were applied to estimate the sizes of segments and subsegments.
This research involved extensively using secondary sources such as directories and databases (Bloomberg Businessweek, Factiva, etc.) to gather information for a technical, market-focused, and commercial market study. In the secondary research process, various sources such as company annual reports, press releases, and investor presentations, white papers, food journals, certified publications, articles from recognized authors, directories, and databases were used to identify and gather information.
Secondary research was primarily used to gather key information about the industry’s supply chain, the overall pool of major players, and market classification and segmentation based on industry trends. It also covered regional markets and key developments from market and technology perspectives.
Extensive primary research was conducted after gathering information on the cannabis market scenario through secondary research. Several interviews with market experts from both demand and supply sides were conducted across major countries in North America, Europe, Asia Pacific, South America, and the Rest of the World. Data was collected through questionnaires, emails, and phone calls. On the supply side, primary sources included industry experts such as Chief X Officers (CXOs), Vice Presidents (VPs), Directors from business development, marketing, research, and development teams, along with key opinion leaders. These interviews provided insights on market statistics, revenue data from products and services, market breakdowns, market size estimates, forecasts, and data triangulation. They also helped understand trends related to cannabis product types, compounds, applications, sources, and regions. Stakeholders from the demand side, such as research institutions, universities, and third-party vendors, were interviewed to gain perspectives on the buyer’s view of the service, current cannabis usage, and future business outlook, all of which influence the overall market.
Note: The three tiers of the companies are defined based on their total revenues in 2023 or 2024, as per
the availability of financial data: Tier 1: Revenue > USD 1 billion; Tier 2: USD 100 million = Revenue = USD 1 billion;
Tier 3: Revenue < USD 100 million.
To know about the assumptions considered for the study, download the pdf brochure
|
COMPANY |
DESIGNATION |
|
Canopy Growth Corporation (Canada) |
R&D Expert |
|
Curaleaf (US) |
Sales Manager |
|
Cresco Labs (US) |
Manager |
|
Green Thumb Industries (GTI) (US) |
Sales Manager |
|
Tilray Brands (US) |
Marketing Manager |
Both the top-down and bottom-up approaches were employed to estimate and verify the overall size of the cannabis market. These methods were also used extensively to determine the size of various market subsegments. The research methodology for estimating the market size includes the following details:

After arriving at the overall market size from the estimation process explained above, the total market was split into several segments and subsegments. The data triangulation and market breakdown procedures were employed, wherever applicable, to estimate the overall cannabis market and arrive at the exact statistics for all segments and subsegments. The data was triangulated by studying various factors and trends from the demand and supply sides. The market size was also validated using both the top-down and bottom-up approaches.
According to the National Institute on Drug Abuse, cannabis refers to the dried leaves, flowers, stems, and seeds of the cannabis plant, which contain various chemical compounds, including tetrahydrocannabinol (THC), the primary psychoactive ingredient responsible for its mind-altering effects. The cannabis market involves the cultivation, processing, distribution, and sale of cannabis and its derivatives for a wide range of applications, including medical, recreational, wellness, and industrial uses. It covers diverse product categories such as dried flower, oils, edibles, topicals, and infused beverages. It is governed by region-specific legal frameworks to ensure product safety, quality standards, and responsible consumer access.
With the given market data, MarketsandMarkets offers customizations according to company-specific scientific needs.
The following customization options are available for the report:
With the given market data, MarketsandMarkets offers customizations according to company-specific scientific needs.
Full forecast, segment splits, and company analysis for all Cannabis Market.
Customize this report to your needs
Get 10% FREE Customization
Customize This Report